ID29601A - PENGGUNAAN (+)-α-(2,3-DIMETOKSIFENIL)-1-(2-(4-FLUOROFENIL)ETIL)-4-PIPERIDINMETANOL UNTUK MENGOBATI GANGGUAN TIDUR - Google Patents

PENGGUNAAN (+)-α-(2,3-DIMETOKSIFENIL)-1-(2-(4-FLUOROFENIL)ETIL)-4-PIPERIDINMETANOL UNTUK MENGOBATI GANGGUAN TIDUR

Info

Publication number
ID29601A
ID29601A IDW20010489A ID20010489A ID29601A ID 29601 A ID29601 A ID 29601A ID W20010489 A IDW20010489 A ID W20010489A ID 20010489 A ID20010489 A ID 20010489A ID 29601 A ID29601 A ID 29601A
Authority
ID
Indonesia
Prior art keywords
piperidinmetanol
dimetoxicylene
fluorofenil
ethyl
sleep disorders
Prior art date
Application number
IDW20010489A
Other languages
English (en)
Indonesian (id)
Inventor
Cesare Mondadori
Stephen M Sorensen
Janice M Hitchcock
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ID29601A publication Critical patent/ID29601A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010489A 1998-08-28 1999-07-29 PENGGUNAAN (+)-α-(2,3-DIMETOKSIFENIL)-1-(2-(4-FLUOROFENIL)ETIL)-4-PIPERIDINMETANOL UNTUK MENGOBATI GANGGUAN TIDUR ID29601A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14313598A 1998-08-28 1998-08-28

Publications (1)

Publication Number Publication Date
ID29601A true ID29601A (id) 2001-09-06

Family

ID=22502745

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010489A ID29601A (id) 1998-08-28 1999-07-29 PENGGUNAAN (+)-α-(2,3-DIMETOKSIFENIL)-1-(2-(4-FLUOROFENIL)ETIL)-4-PIPERIDINMETANOL UNTUK MENGOBATI GANGGUAN TIDUR

Country Status (32)

Country Link
EP (2) EP1105132B1 (de)
JP (1) JP2002523460A (de)
KR (3) KR100682799B1 (de)
CN (1) CN1127954C (de)
AT (1) ATE249830T1 (de)
AU (1) AU764604B2 (de)
BG (2) BG109953A (de)
BR (1) BR9913242A (de)
CA (2) CA2341891C (de)
CZ (1) CZ300781B6 (de)
DE (2) DE69911436T2 (de)
DK (1) DK1105132T3 (de)
EA (1) EA003791B1 (de)
EE (1) EE04951B1 (de)
ES (1) ES2204146T3 (de)
HK (1) HK1040907B (de)
HR (2) HRP20010140A2 (de)
HU (1) HUP0202145A3 (de)
ID (1) ID29601A (de)
IL (2) IL141603A0 (de)
ME (1) MEP20308A (de)
MX (1) MXPA01002026A (de)
NO (2) NO20010984L (de)
NZ (1) NZ510083A (de)
PL (1) PL195022B1 (de)
PT (1) PT1105132E (de)
SK (1) SK284858B6 (de)
TR (1) TR200100670T2 (de)
TW (1) TWI233802B (de)
UA (1) UA74773C2 (de)
WO (1) WO2000012090A1 (de)
ZA (1) ZA200101466B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099076A1 (en) 2000-05-25 2002-07-25 Richard Scheyer D. Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
DK1534391T3 (da) 2002-07-19 2007-06-11 Biovitrum Ab Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169096A (en) 1985-07-02 1992-12-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl-piperidine-methanol derivatives
US4877798A (en) * 1987-11-23 1989-10-31 Merrell Dow Pharmaceuticals Inc. Treatment of fibromyalgia
ATE102482T1 (de) * 1988-01-21 1994-03-15 Merrell Dow Pharma Verwendung von 1,4-disubstituierten-piperidinyl- verbindungen zur herstellung eines arzneimittels zur behandlung von schlaflosigkeit.
WO1991018602A1 (en) 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
JPH05134149A (ja) * 1991-11-08 1993-05-28 Nippondenso Co Ltd 光半導体モジユール
US5618824A (en) 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
EP0796619A1 (de) * 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Verwendung von (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-Fluorophenyl)ethyl)-4-Piperidinmethanol zur Behandlung von Depressionen und bipolaren Erkrankungen
US9702597B1 (en) 2016-02-18 2017-07-11 King Fahd University Of Petroleum And Minerals System and method for preventing absorbent crystallization in a continuously operating solar-powered absorption cooling system with hybrid storage

Also Published As

Publication number Publication date
CA2341891A1 (en) 2000-03-09
NZ510083A (en) 2003-08-29
ATE249830T1 (de) 2003-10-15
HRP20080389A2 (hr) 2008-11-30
TR200100670T2 (tr) 2001-06-21
TWI233802B (en) 2005-06-11
NO20091111L (no) 2001-04-25
BR9913242A (pt) 2001-05-15
CZ2001726A3 (en) 2001-06-13
CA2629396A1 (en) 2000-03-09
EP1362589A1 (de) 2003-11-19
DE69911436D1 (de) 2003-10-23
HRP20010140A2 (en) 2002-02-28
DK1105132T3 (da) 2003-11-24
CA2341891C (en) 2009-05-12
PT1105132E (pt) 2004-02-27
HK1040907B (zh) 2004-04-02
JP2002523460A (ja) 2002-07-30
EP1105132A1 (de) 2001-06-13
EP1105132B1 (de) 2003-09-17
KR100735513B1 (ko) 2007-07-06
CN1127954C (zh) 2003-11-19
AU764604B2 (en) 2003-08-21
HK1040907A1 (en) 2002-06-28
KR20060057029A (ko) 2006-05-25
IL141603A (en) 2006-08-20
ZA200101466B (en) 2002-05-21
CZ300781B6 (cs) 2009-08-12
KR100682799B1 (ko) 2007-02-15
NO20010984L (no) 2001-04-25
KR20010073026A (ko) 2001-07-31
BG65416B1 (bg) 2008-07-31
IL141603A0 (en) 2002-03-10
MEP20308A (en) 2010-06-10
AU5135999A (en) 2000-03-21
PL195022B1 (pl) 2007-08-31
NO20010984D0 (no) 2001-02-27
PL346342A1 (en) 2002-02-11
SK284858B6 (sk) 2006-01-05
MXPA01002026A (es) 2003-03-27
ES2204146T3 (es) 2004-04-16
DE69911436T2 (de) 2004-07-01
EE200100122A (et) 2002-06-17
KR20060023197A (ko) 2006-03-13
SK2692001A3 (en) 2001-07-10
HUP0202145A2 (hu) 2003-01-28
BG105289A (en) 2001-11-30
DE69941134D1 (de) 2009-08-27
EA003791B1 (ru) 2003-10-30
HUP0202145A3 (en) 2003-02-28
CN1315861A (zh) 2001-10-03
BG109953A (en) 2007-12-28
KR100764532B1 (ko) 2007-10-09
WO2000012090A1 (en) 2000-03-09
EE04951B1 (et) 2008-02-15
UA74773C2 (en) 2006-02-15
EP1362589B1 (de) 2009-07-15
EA200100201A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
PT867184E (pt) Utilizacao de tiagabina para o tratamento de desordens do sono
PL333920A1 (en) 3-pyridyl enantiomers and their application as pain-relieving agents
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
MY111623A (en) Neuroprotective compounds
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
EA200001058A1 (ru) Новые способы лечения нервных расстройств
BR9708037A (pt) Método para o tratamento de abuso de substância
RU97101420A (ru) Способ лечения тонзиллита
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
EA200200656A1 (ru) НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-е]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ
DE69800906D1 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
EA200200559A1 (ru) Способ лечения и профилактики нейродегенеративных состояний
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами